Business News • PR NewsWire • Kiadis Pharma Initiates Collaboration for Personalized Immunotherapies Using ATIR[TM]with Technische Universität München within Munich Biotech Cluster

Kiadis Pharma Initiates Collaboration for Personalized Immunotherapies Using ATIR[TM]with Technische Universität München within Munich Biotech Cluster

Kiadis Pharma Initiates Collaboration for Personalized Immunotherapies Using ATIR[TM]with Technische Universität München within Munich Biotech Cluster

AMSTERDAM, January 29, 2014 /PRNewswire/ -- ~ Prof. Dr. Angela Krackhardt from the Klinikum rechts der Isar of the Technische Universität München to lead the project ~ Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing...

View More : http://www.prnewswire.com/news-releases/kiadis-pharma-initiates-collaboration-for-personalized-immunotherapies-using-ati...

Releted News by prnewswire

JSWA Accepting Exhibitor Applications for Sewage Works Exhibition '14 Osaka at Intex Osaka July 22-25, 2014

Coms Promotes Talent to Marketing Director